COVIDLIGHT
A Health Canada and US Ethics board reviewed Clinical Trial (ITA #315768)
Thank you for your interest. At this time we have enrolled all our participants and have stopped the recruitment process for the COVIDLight study.
Are you COVID-19 Positive?
Help us
Help many
We are running a clinical trial designed for virtual and at-home participation. You can join and participate in the study remotely, without leaving the comfort of your home. The study is testing our investigational light therapy device (photobiomodulation device) to see if we can help people recover faster from COVID-19.
.png)
Try a study device that may accelerate your recovery from COVID-19
Complete a short daily questionnaire online
Be a part of a new potential solution for treating COVID-19
Eligibility
To participate remotely, you must be:
18-65 years old
COVID-19 Positive
Within 10 days of your symptom onset
Study Treatment
It's simple and non-invasive.
Place one light-emitting diode (LED) of the study device on your chest and clip another small LED to one nostril for 20 minutes a day. Here's what we believe it may do for you:
.png)
.png)
.png)
Nitric Oxide is a compound that our bodies make and one of its functions is to help with increasing blood flow especially in the lung and can make it easier to have proper oxygen levels.
May Accelerate Nitric Oxide Release
May Accelerate Nitric Oxide Release
The thymus gland is an organ that holds cells that fight infection called T cells.
May Stimulate the
Thymus Gland
May Stimulate the Thymus Gland
by increasing the levels of ATP, the energy the cells rely upon
May Increase Cellular Energy
May Increase Cellular Energy
.png)
May Act as an Anti-Inflammatory Therapy
Hover over text to learn more
Compensation
Participants
Referrals
Eligible participants will receive up to $500 for participation in the trial.
If you are looking for information for friends and family, you could be eligible to receive a referral fee of $50 for every participant you refer. This will be paid to you if your referral meets the study eligibility criteria and is enrolled in this trial.
Step 1
Registration
Click "Get Started" to create an account in our trial database called REDCap Cloud. REDCap Cloud is an international platform that complies with patient data privacy standards.
It takes about 15 minutes and will gather basic background information about you to determine if you qualify for our trial.
Watch our step-by-step video to help you with the registration process.
Enrollment Process
Step 2
Am I eligible?
If eligible, you will be allocated to one of two groups: the study treatment group or the control group.
Study Treatment Group
Vielight Device
Pulse Oximeter
Daily Survey
Paid up to $500
Control Group
Pulse Oximeter
Daily Survey
Paid up to $500
If you are assigned to the study treatment group, you’ll receive a Vielight device delivered to you home for your daily use. In either group, you will also receive a pulse oximeter and you'll fill out a daily survey telling us how you feel. This information is used to determine when your symptoms are gone, so that we know how long it took for you to get better.
Step 3
Virtual Telehealth Visit
Once you are assigned to your group, we will contact you to have a telehealth call with one of our physicians right from the comfort of your own home. All you need is an internet connection, speakers, and a microphone on your phone, laptop, or tablet.
Interested and have questions?
Our knowledgeable team of researchers will be happy to answer your questions. Please fill out the form or call to contact us. We respond within 24 hours.
Email Closed
Study team: Study Closed
Study educator: Study Closed
By contacting us, you are requesting additional information regarding the trial participation and give us consent to contact you to provide such information.
Study is Concluded.
References & Science
1
1
Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19
2
Photodynamic Therapy for the Treatment of COVID-19
3
Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review.
4
A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19
Light as a potential treatment for pandemic coronavirus infections: A perspective
5
6
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms (COVIDLight)
Conducting a clinical trial for COVID-19 medical devices: List of authorized clinical trials
7
8
A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19
Evaluation of Adjunctive Photobiomoulation for COVID-19 Pneumonia via Clinical Status & Pulmonary Severity
9
This study is sponsored by
About Vielight Inc. and Photobiomodulation (PBM)
Vielight Inc. is a global leader in photobiomodulation (light therapy) research, innovation and its practical applications. Our devices are used by the U.S. Veterans Affairs, major universities, research labs, and tens of thousands of customers all over the world.
For more information about Vielight research in photobiomodulation please click "Learn More" below
.jpg)